NASDAQ:XFOR
X4 Pharmaceuticals
- Stock
Last Close
0.69
30/08 20:00
Market Cap
103.11M
Beta: 0.25
Volume Today
726.85K
Avg: 1.81M
PE Ratio
−1.27
PFCF: −1.65
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
net income | -13.22M - | -22.98M 73.82% | -33.88M 47.45% | -43.02M 26.99% | -52.81M 22.75% | -62.13M 17.66% | -88.70M 42.76% | -93.87M 5.83% | -101.17M 7.78% | |
depreciation and amortization | 389K - | 285K 26.74% | 195K 31.58% | 155K 20.51% | 103K 33.55% | 351K 240.78% | 499K 42.17% | 513K 2.81% | 419K 18.32% | |
deferred income tax | -1K - | -1.39M 139,100% | -269K 80.68% | -2.15M - | -5.78M 168.42% | -6.68M 15.57% | ||||
stock based compensation | 126K - | 644K 411.11% | 906K 40.68% | 5.62M 520.31% | 2.05M 63.52% | 5.43M 164.78% | 6.18M 13.85% | 5.20M 15.87% | 8.69M 67.09% | |
change in working capital | 1.45M - | -517K 135.73% | 3.42M 762.28% | -4.46M 230.29% | -3.24M 27.46% | -4.06M 25.56% | -1.50M 63.13% | 5.74M 482.91% | 1.23M 78.49% | |
accounts receivables | -610K - | |||||||||
inventory | 610K - | |||||||||
accounts payables | 77K - | 1.26M 1,541.56% | 182K 85.60% | -1.34M 835.71% | -2.75M 105.53% | 1.03M 137.46% | 1.17M 13.09% | 3.42M 193.74% | 1.23M 63.97% | |
other working capital | 1.37M - | -1.78M 230.00% | 3.24M 282.03% | -3.12M 196.30% | -484K 84.50% | -5.09M 952.48% | -2.66M 47.70% | 2.31M 186.75% | -1.23M 153.40% | |
other non cash items | 441K - | 2.32M 425.17% | 1.75M 24.44% | 804K 54.06% | 7.99M 893.53% | 7.38M 7.66% | 19.29M 161.51% | 5.32M 72.44% | -4.45M 183.71% | |
net cash provided by operating activities | -10.82M - | -21.64M 100.06% | -27.87M 28.80% | -40.90M 46.76% | -48.05M 17.49% | -58.82M 22.40% | -70.91M 20.55% | -77.10M 8.74% | -96.51M 25.17% | |
investments in property plant and equipment | -170K - | -73K 57.06% | -42K 42.47% | -34K 19.05% | -174K 411.76% | -1.36M 682.76% | -615K 54.85% | -103K 83.25% | -60K 41.75% | |
acquisitions net | 26.41M - | |||||||||
purchases of investments | -4.80M - | -16.82M 250.33% | ||||||||
sales maturities of investments | 2M - | |||||||||
other investing activites | -77K - | -65K 15.58% | 76K 216.92% | 1M - | 4.80M - | |||||
net cash used for investing activites | -247K - | -138K 44.13% | 34K 124.64% | -34K 200% | 27.23M 80,194.12% | -1.36M 105.00% | -615K 54.85% | -103K 83.25% | -14.88M 14,349.51% | |
debt repayment | -1.03M - | -250K 75.63% | -2.35M 840% | -4.67M 98.60% | -9.37M 100.73% | -12.39M 32.24% | -795K - | |||
common stock issued | 66M - | 139.39M - | -277K 100.20% | 75.98M 27,531.41% | 122.63M 61.39% | 60.00M 51.07% | ||||
common stock repurchased | -12K - | -87K 625% | -197K 126.44% | 19.95M - | -277K 101.39% | -2M 622.02% | -12 100.00% | |||
dividends paid | -45.68M - | -19.95M - | -12.39M 37.91% | -12 - | ||||||
other financing activites | 12.54M - | 18.48M 47.37% | 83.49M 351.69% | 136K 99.84% | 10.64M 7,724.26% | 37.72M 254.52% | 260K 99.31% | -4.61M 1,871.53% | 28.52M 719.13% | |
net cash used provided by financing activities | 11.51M - | 18.15M 57.73% | 101.26M 458.01% | -4.53M 104.47% | 140.66M 3,204.41% | 12.39M 91.19% | 74.25M 499.04% | 117.23M 57.90% | 88.52M 24.49% | |
effect of forex changes on cash | -122K - | -94K 22.95% | 333K 454.26% | -286K 185.89% | -250K 12.59% | 402K 260.80% | -319K 179.35% | -105K 67.08% | 99K 194.29% | |
net change in cash | 320K - | -3.72M 1,263.75% | 73.76M 2,080.61% | -45.75M 162.03% | 119.59M 361.37% | -47.38M 139.62% | 2.41M 105.08% | 39.92M 1,559.19% | -22.78M 157.06% | |
cash at beginning of period | 6.44M - | 6.76M 4.97% | 3.04M 55.10% | 77.15M 2,441.94% | 8.50M 88.98% | 128.09M 1,407.25% | 80.70M 36.99% | 83.11M 2.98% | 123.03M 48.03% | |
cash at end of period | 6.76M - | 3.04M 55.10% | 76.79M 2,430.25% | 31.39M 59.12% | 128.09M 308.00% | 80.70M 36.99% | 83.11M 2.98% | 123.03M 48.03% | 100.25M 18.52% | |
operating cash flow | -10.82M - | -21.64M 100.06% | -27.87M 28.80% | -40.90M 46.76% | -48.05M 17.49% | -58.82M 22.40% | -70.91M 20.55% | -77.10M 8.74% | -96.51M 25.17% | |
capital expenditure | -170K - | -73K 57.06% | -42K 42.47% | -34K 19.05% | -174K 411.76% | -1.36M 682.76% | -615K 54.85% | -103K 83.25% | -60K 41.75% | |
free cash flow | -10.99M - | -21.71M 97.63% | -27.91M 28.56% | -40.94M 46.66% | -48.23M 17.81% | -60.18M 24.78% | -71.52M 18.84% | -77.20M 7.95% | -96.57M 25.09% |
All numbers in USD (except ratios and percentages)